View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Paclitaxel 80 / Gemcitabine 1000 / Cisplatin 70, Bladder Cancer
Protocol-ID: 1359 V1.3 (Mini), PACL80/GEMC1000/CISP70, Urinary Bladder CaIndication(s)
- Bladder Cancer; ICD-10 C67.-
- Renal Pelvic Carcinoma; ICD-10 C65
Links
- EORTC Intergroup Study 30987: Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients With Metastatic or Locally Advanced Urothelial Cancer Without Prior Systemic Therapy. [clinicaltrials.gov]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 08.01.2023